X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
P&G: Foussed approach paying off - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Oct 31, 2000

    P&G: Foussed approach paying off

    P&G Health & Hygiene, the 51% Indian arm of global FMCG major Procter & Gamble, has made a terrific start in its first quarter of FY01. Though the turnover was stagnant in value terms, the company's expenditure took a 3% drop. As a result, P&G's operating margins improved to 23.4%.

    (Rs m) 1QFY00 1QFY01 Change FY00
    Sales 1,193 1,201 0.7% 4,751
    Other Income 2 14 683.3% 52
    Expenditure 949 920 -3.0% 175
    Operating Profit (EBDIT) 244 281 15.0% 4,576
    Operating Profit Margin (%) 20.5% 23.4%   96.3%
    Interest 11 1 -87.6% 2
    Depreciation 58 73 26.7% 10
    Profit before Tax 177 221 24.5% 74
    Tax 28 35 27.4% 9
    Profit after Tax/(Loss) 150 185 24.0% 65
    Net profit margin (%) 12.5% 15.4%   1.4%
    No. of Shares (eoy) (m) 21.6 21.6   21.6
    Earnings per share* 27.6 34.3   3.0
    *(annualised)        
    Current P/e ratio   15.9    

    The sales turnover though, is not comparable, as P&G discontinued shampoo manufacturing for its parent's 100% subsidiary P&G Home Products. If the impact of the shampoo manufacture revenues is removed, the sales growth amounts to around 14%.

    A surge in its other income, coupled with a huge decline in its interest outgo helped P&G improve its 1QFY01 bottomline by 24% compared to the corresponding quarter in FY00.

    P&G India has consciously focussed on becoming a two product company viz., Sanitary Napkins (Whisper) and anti-cold (Vicks). The company's products enjoy immense brand value. Unlike compatriot Hindustan Lever, P&G's strategy has revolved around premium positioning of both its product categories. In a sense, the company has been focussing on margins (value) rather than volumes.

    The stock trades at Rs 547, a P/e multiple of 15.9 times its annualised FY01 expected earnings. The stock used to trade at a P/e ratio of 25-30 times, before the tech boom came.

    Given the company's clear strategy on focusing on two products, as also its premium positioning, the company is better placed than most FMCG's to clock double digit growth figures both in its topline and bottomline in the medium term. In the long term however, P&G's two prduct focus might become a bane as competition picks up. There are also concerns regarding its parent's two 100% subsidiaries in India.

     

     

    Equitymaster requests your view! Post a comment on "P&G: Foussed approach paying off". Click here!

      
     

    More Views on News

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    P&G: Strong Core Performance (Quarterly Results Update - Detailed)

    Oct 5, 2016

    Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: A Stable Quarter (Quarterly Results Update - Detailed)

    May 6, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 12% YoY during the quarter.

    P&G: Margins Go Through the Roof (Quarterly Results Update - Detailed)

    Feb 9, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 62% YoY during the quarter.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    P&G HYGIENE SHARE PRICE


    Aug 23, 2017 11:24 AM

    TRACK P&G HYGIENE

    • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    P&G HYGIENE 8-QTR ANALYSIS

    Detailed Quarterly Results With Charts

    COMPARE P&G HYGIENE WITH

    MARKET STATS